- Home
- MMSI vs ALKS Comparison
MMSI vs ALKS Comparison
Compare MMSI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMSI
- ALKS
- Stock Information
- Founded
- MMSI 1987
- ALKS 1987
- Country
- MMSI United States
- ALKS Ireland
- Employees
- MMSI N/A
- ALKS N/A
- Industry
- MMSI Medical/Dental Instruments
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- MMSI Health Care
- ALKS Health Care
- Exchange
- MMSI Nasdaq
- ALKS Nasdaq
- Market Cap
- MMSI 5.6B
- ALKS 5.4B
- IPO Year
- MMSI 1990
- ALKS 1991
- Fundamental
- Price
- MMSI $105.71
- ALKS $33.02
- Analyst Decision
- MMSI Strong Buy
- ALKS Buy
- Analyst Count
- MMSI 10
- ALKS 13
- Target Price
- MMSI $111.70
- ALKS $39.50
- AVG Volume (30 Days)
- MMSI 688.8K
- ALKS 1.7M
- Earning Date
- MMSI 04-29-2025
- ALKS 04-30-2025
- Dividend Yield
- MMSI N/A
- ALKS N/A
- EPS Growth
- MMSI 25.31
- ALKS 3.47
- EPS
- MMSI 2.03
- ALKS 2.17
- Revenue
- MMSI $1,356,514,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- MMSI $11.09
- ALKS N/A
- Revenue Next Year
- MMSI $6.17
- ALKS $4.37
- P/E Ratio
- MMSI $51.92
- ALKS $15.10
- Revenue Growth
- MMSI 7.88
- ALKS N/A
- 52 Week Low
- MMSI $70.70
- ALKS $22.90
- 52 Week High
- MMSI $111.45
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- MMSI 59.45
- ALKS 42.12
- Support Level
- MMSI $98.85
- ALKS $33.22
- Resistance Level
- MMSI $105.78
- ALKS $34.45
- Average True Range (ATR)
- MMSI 2.41
- ALKS 0.96
- MACD
- MMSI 0.68
- ALKS -0.23
- Stochastic Oscillator
- MMSI 98.97
- ALKS 28.87
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.